Home › NDC Lookup › RxCUI directory › RxCUI 2680300

Acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Or... — RxCUI 2680300

RxNorm drug concept · Semantic clinical drug
RxCUI 2680300 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2680300
Official nameAcetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution; acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution; acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaifenesin 400 MG per 20 ML Oral Solution
FDA products mapped10
Package NDCs mapped12
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 32.5 MG/ML / dextromethorphan hydr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution RxCUI 2680300

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Dextromethorphan 3289
    • Guaifenesin 5032
    • Acetaminophen / dextromethorphan / guaifenesin 689775
    • Dextromethorphan hydrobromide 102490
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / dextromethorphan / guaifenesin Oral Solution 375971
    • Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Solution 2646565
    • Acetaminophen / dextromethorphan / guaifenesin Oral Liquid Product 1155912
    • Acetaminophen / dextromethorphan / guaifenesin Oral Product 1155913
    • Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Liquid Product 2659921
    • Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Product 2662330
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acetaminophen 32.5 MG/ML 336021
    • Dextromethorphan hydrobromide 1 MG/ML 1020137
    • Guaifenesin 20 MG/ML 316011

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 32.5 MG/ML SCDC · 336021
  • Dextromethorphan hydrobromide 1 MG/ML SCDC · 1020137
  • Guaifenesin 20 MG/ML SCDC · 316011
  • Acetaminophen / dextromethorphan / guaifenesin Oral Solution SCDF · 375971
  • Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Solution SCDFP · 2646565
  • Acetaminophen / dextromethorphan / guaifenesin Oral Liquid Product SCDG · 1155912
  • Acetaminophen / dextromethorphan / guaifenesin Oral Product SCDG · 1155913
  • Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Liquid Product SCDGP · 2659921
  • Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Product SCDGP · 2662330

📦 FDA Products & Package NDCs

10 products · 12 package NDCs
12 package NDCs map to RxCUI 2680300 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00031-0100-04 1 BOTTLE in 1 CARTON (0031-0100-04) / 118 mL in 1 BOTTLE Robitussin Maximum Strength Severe Multi-Symptom Cough Cold Flu Haleon US Holdings LLC 2024-02-15
00031-0100-08 1 BOTTLE in 1 CARTON (0031-0100-08) / 237 mL in 1 BOTTLE Robitussin Maximum Strength Severe Multi-Symptom Cough Cold Flu Haleon US Holdings LLC 2024-02-15
00113-2009-34 1 BOTTLE in 1 CARTON (0113-2009-34) / 237 mL in 1 BOTTLE (0... GOOD SENSE TUSSIN L. Perrigo Company 2026-01-08
11673-0794-01 1 KIT in 1 KIT (11673-794-01) * 177 mL in 1 BOTTLE, PLASTI... Maximum Strength Daytime Severe and Nighttime Cold and Flu TARGET Corporation 2024-05-01
42507-0581-26 1 BOTTLE in 1 CARTON (42507-581-26) / 118 mL in 1 BOTTLE (4... Tussin Severe HyVee Inc 2026-01-28
51316-0089-08 1 BOTTLE in 1 CARTON (51316-089-08) / 237 mL in 1 BOTTLE CVS PHARMACY MS Adult Severe Multi Symptom Cough Cold Flu CVS PHARMACY 2025-06-23
51316-0189-26 1 BOTTLE in 1 CARTON (51316-189-26) / 118 mL in 1 BOTTLE SEVERE COUGH COLD AND FLU CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED 2025-08-29
51316-0189-34 1 BOTTLE in 1 CARTON (51316-189-34) / 237 mL in 1 BOTTLE SEVERE COUGH COLD AND FLU CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED 2025-08-29
57896-0596-08 237 mL in 1 BOTTLE (57896-596-08) Geri Care Tussin CF Max GERI-CARE PHARMACEUTICAL CORP 2025-12-01
58593-0005-08 237 mL in 1 BOTTLE (58593-005-08) Rompe Pecho Max Efficient Laboratories Inc 2026-06-01
70000-0739-01 1 BOTTLE in 1 CARTON (70000-0739-1) / 118 mL in 1 BOTTLE LEADER TUSSIN CF Cardinal Health 110, LLC. dba Leader 2025-09-30
76162-0198-26 1 BOTTLE in 1 CARTON (76162-198-26) / 118 mL in 1 BOTTLE TOPCARE TUSSIN CF MAX Topco Associates LLC 2026-02-11
Observed labelers: CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED (2) · Haleon US Holdings LLC (2) · Cardinal Health 110, LLC. dba Leader (1) · CVS PHARMACY (1) · Efficient Laboratories Inc (1) · GERI-CARE PHARMACEUTICAL CORP (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.